From: Predicting conversion of brain β-amyloid positivity in amyloid-negative individuals
Dataset | Model | Featuresa | AUROC (95% CI) | AUPRC (95% CI) | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) |
---|---|---|---|---|---|---|---|---|
A. ADNI (development set) | Model 1 | Age, gender, APOE ε4 carriers (3) | 0.674 (0.666–0.683) | 0.374 (0.364–0.384) | 0.606 (0.595–0.616) | 0.692 (0.668–0.715) | 0.373 (0.355–0.392) | 0.853 (0.849–0.858) |
Model 2 | Age, gender, APOE ε4 carriers, global SUVR (4) | 0.814 (0.806–0.821) | 0.549 (0.534–0.564) | 0.744 (0.707–0.780) | 0.727 (0.690–0.764) | 0.454 (0.430–0.478) | 0.905 (0.896–0.913) | |
Model 3 | Age, gender, APOE ε4 carriers, global SUVR, regional SUVR (44) | 0.841 (0.832–0.849) | 0.627 (0.610–0.645) | 0.600 (0.581–0.619) | 0.869 (0.862–0.875) | 0.579 (0.562–0.597) | 0.878 (0.873–0.884) | |
B. SMC (external validation set) | Model 2 | Age, gender, APOE ε4 carriers, global SUVR (4) | 0.900 | 0.625 | 1.000 | 0.700 | 0.526 | 1.000 |